Patent ID: 11918633
Assignee: BIOMARIN PHARMACEUTICAL INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 5:
6. The method of claim 4, wherein the induction dosage is administered for a duration of between 2 weeks and 6 weeks, the titration dosage is administered for a duration of between 3 weeks and 8 weeks, and the maintenance dosage is administered for a duration of between 50 weeks and 80 weeks; wherein optionally
a. the induction dosage is administered for a duration of about 4 weeks, the titration dosage is administered for a duration of about 5 weeks, and the maintenance dosage is administered for a duration of between 56 weeks and 64 weeks; or
b. the maintenance dosage is comprised of a first maintenance dosage of between 70 mg per week and 280 mg per week, a second maintenance dosage of between 140 mg per week and 560 mg per week, and a third maintenance dosage of between 210 mg per week and 840 mg per week; wherein optionally the first maintenance dosage is administered for a duration of between 16 weeks and 24 weeks, the second maintenance dosage is administered for a duration of about 16 weeks, and the third maintenance dosage is administered for a duration of about 24 weeks.